Rubric Capital Management LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Telesat Corporation 13G/A Amendment 3
TSAT · 879512309
 0% 8/14/2026
Event 6/30/2026
MeiraGTx Holdings plc 13G/A Amendment 1
MGTX · G59665102
 9.8% 8/14/2026
Event 6/30/2026
Nurix Therapeutics, Inc. 13G
NRIX · 67080M103
 7.0% 8/14/2026
Event 6/30/2026
MannKind Corporation 13G
MNKD · 56400P706
 5.8% 8/14/2026
Event 6/30/2026
Enovis Corporation 13G
ENOV · 194014502
 6.8% 8/14/2026
Event 6/30/2026
Mission Produce, Inc. 13G
AVO · 60510V108
 6.8% 8/14/2026
Event 6/30/2026
Ardelyx, Inc. 13G
ARDX · 039697107
 6.6% 8/14/2026
Event 6/30/2026
Zymeworks Inc. 13G/A Amendment 2
ZYME · 98985Y108
 9.5% 5/15/2026
Event 3/31/2026
ARS Pharmaceuticals, Inc. 13G/A Amendment 1
SPRY · 82835W108
 8.1% 5/15/2026
Event 3/31/2026
Schrodinger, Inc. 13G/A Amendment 3
SDGR · 80810D103
 9.3% 5/15/2026
Event 3/31/2026
Prothena Corporation Public Limited Company 13G/A Amendment 1
PRTA · G72800108
 9.3% 5/15/2026
Event 3/31/2026
New Fortress Energy Inc. 13G/A Amendment 2
NFE · 644393100
 0% 5/15/2026
Event 3/31/2026
Liberty Latin America Ltd. 13G
LILA · G9001E102
 9.9% 5/15/2026
Event 3/31/2026
Edgewell Personal Care Company 13G
EPC · 28035Q102
 8.6% 5/15/2026
Event 3/31/2026
Edesa Biotech, Inc. 13G
EDSA · 27966L306
 7.7% 5/15/2026
Event 3/31/2025
Calavo Growers, Inc. 13G
CVGW · 128246105
 7.9% 5/15/2026
Event 3/31/2026
Zymeworks Inc. 13G/A Amendment 1
ZYME · 98985Y108
 7.7% 2/13/2026
Event 12/31/2025
Trevi Therapeutics, Inc. 13G/A Amendment 1
TRVI · 89532M101
 2.9% 2/13/2026
Event 12/31/2025
ARS Pharmaceuticals, Inc. 13G
SPRY · 82835W108
 6.3% 2/13/2026
Event 12/31/2025
Schrodinger, Inc. 13G/A Amendment 2
SDGR · 80810D103
 6.5% 2/13/2026
Event 12/31/2025
ReNew Global plc 13G/A Amendment 1
RNW · G7500M104
 4.5% 2/13/2026
Event 12/31/2025
QuidelOrtho Corporation 13G/A Amendment 3
QDEL · 219798105
 5.6% 2/13/2026
Event 12/31/2025
Prothena Corporation Public Limited Company 13G
PRTA · G72800108
 6.8% 2/13/2026
Event 12/31/2025
MeiraGTx Holdings plc 13G
MGTX · G59665102
 7.9% 2/13/2026
Event 12/31/2025
Liberty Global Ltd. 13G
LBTYA · G61188101
 5.7% 2/13/2026
Event 12/31/2025
Cimpress plc 13G
CMPR · G2143T103
 6.2% 2/13/2026
Event 12/31/2025
BGC Group, Inc. 13G
BGC · 088929104
 5.8% 2/13/2026
Event 12/31/2025
Arcutis Biotherapeutics, Inc. 13G/A Amendment 2
ARQT · 03969K108
 6.8% 2/13/2026
Event 12/31/2025
Kiniksa Pharmaceuticals International, plc 13G/A Amendment 4
KNSA · G52694109
 7.4% 2/13/2026
Event 12/31/2025
Collegium Pharmaceutical, Inc. 13G/A Amendment 2
COLL · 19459J104
 4.7% 2/13/2026
Event 12/31/2025
Talen Energy Corporation 13G/A Amendment 3
TLN · 87422Q109
 7.9% 11/14/2025
Event 9/30/2025
Ecovyst Inc. 13G
ECVT · 27923Q109
 9.1% 11/14/2025
Event 9/30/2025
Heron Therapeutics, Inc. /DE/ 13D/A Amendment 5
HRTX · 427746102
 15.9% 10/17/2025
Event 10/15/2025
Heron Therapeutics, Inc. /DE/ 13D/A Amendment 4
HRTX · 427746102
 17.5% 8/12/2025
Event 8/8/2025
Talen Energy Corporation 13G/A Amendment 2
TLN · 87422Q109
 9.9% 7/9/2025
Event 6/30/2025
QuidelOrtho Corporation 13G/A Amendment 2
QDEL · 219798105
 6.9% 7/9/2025
Event 6/30/2025
OPKO Health, Inc. 13G/A Amendment 1
OPK · 68375N103
 6.0% 7/9/2025
Event 6/30/2025
Integra Lifesciences Holdings Corporation 13G/A Amendment 1
IART · 457985208
 9.5% 7/9/2025
Event 6/30/2025
Ovid Therapeutics Inc. 13G/A Amendment 2
OVID · 690469101
 0.7% 7/9/2025
Event 6/30/2025
Adaptive Biotechnologies Corporation 13G/A Amendment 1
ADPT · 00650F109
 4.1% 7/9/2025
Event 6/30/2025
Kiniksa Pharmaceuticals International, plc 13G/A Amendment 3
KNSA · G52694109
 9.2% 7/9/2025
Event 6/30/2025
Trevi Therapeutics, Inc. 13G
TRVI · 89532M101
 7.1% 7/9/2025
Event 6/30/2025
TransAlta Corporation 13G
TAC · 89346D107
 5.4% 7/9/2025
Event 6/30/2025
New Fortress Energy Inc. 13G/A Amendment 1
NFE · 644393100
 8.9% 5/14/2025
Event 3/31/2025
Kiniksa Pharmaceuticals International, plc 13G/A Amendment 2
KNSA · G52694109
 8.1% 5/14/2025
Event 3/31/2025
Golar LNG Limited 13G/A Amendment 4
GLNG · G9456A100
 8.6% 5/14/2025
Event 3/31/2025
GoodRx Holdings, Inc. 13G/A Amendment 1
GDRX · 38246G108
 0% 5/14/2025
Event 3/31/2025
Dole Plc 13G/A Amendment 1
DOLE · G27907107
 4.4% 5/14/2025
Event 3/31/2025
Collegium Pharmaceutical, Inc. 13G/A Amendment 1
COLL · 19459J104
 9.3% 5/14/2025
Event 3/31/2025
Integra Lifesciences Holdings Corporation 13G
IART · 457985208
 6.0% 5/14/2025
Event 3/31/2025
Golar LNG Ltd 13G/A Amendment 3
GLNG · G9456A100
 7.4%
Checked 5% or less
 2/13/2025
Event 12/31/2024
Pediatrix Medical Group, Inc. 13G/A Amendment 1
MD · 58502B106
 3.7% 2/13/2025
Event 12/31/2024
Seaport Entertainment Group Inc. 13G/A Amendment 1
SEG · 812215200
 4.5% 2/13/2025
Event 12/31/2024
Trevi Therapeutics, Inc. 13G/A Amendment 3
TRVI · 89532M101
 4.7% 2/13/2025
Event 12/31/2024
Schrodinger, Inc. 13G/A Amendment 1
SDGR · 80810D103
 7.9% 2/13/2025
Event 12/31/2024
GoodRx Holdings, Inc. 13G
GDRX · 38246G108
 5.6% 2/13/2025
Event 12/31/2024
QuidelOrtho Corp 13G/A Amendment 1
QDEL · 219798105
 8.3% 2/13/2025
Event 12/31/2024
Collegium Pharmaceutical, Inc 13G
COLL · 19459J104
 7.3% 2/13/2025
Event 12/31/2024
Talen Energy Corp 13G/A Amendment 1
TLN · 87422Q109
 13.3% 2/13/2025
Event 12/31/2024
New Fortress Energy Inc. 13G
NFE · 644393100
 5.6% 2/13/2025
Event 12/31/2024
Coherus BioSciences, Inc. 13G/A Amendment 1
CHRS · 19249H103
 4.6% 2/13/2025
Event 12/31/2024